Shrestha, B., Sun, Y., Faisal, F., Kim, V., Soares, K., Blair, A., . . . Zheng, L. (2017). Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. Cancer Med.
Citação norma ChicagoShrestha, Bikram, et al. "Long‐term Survival Benefit of Upfront Chemotherapy in Patients With Newly Diagnosed Borderline Resectable Pancreatic Cancer." Cancer Med 2017.
MLA CitationShrestha, Bikram, et al. "Long‐term Survival Benefit of Upfront Chemotherapy in Patients With Newly Diagnosed Borderline Resectable Pancreatic Cancer." Cancer Med 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.